Invesco China Health Care Equity Fd.C H/  LU2243645046  /

Fonds
NAV2024-05-14 Chg.+0.0300 Type of yield Investment Focus Investment company
4.9700SGD +0.61% reinvestment Equity Sector Health / Pharma Invesco Management 

Investment strategy

The objective of the Fund is to achieve long term capital growth. The Fund invests in Chinese healthcare companies listed on the Shanghai or Shenzhen Stock Exchanges, traded via Stock Connect as well as those listed or traded elsewhere, included Qualified Foreign Investors (QFI). The Fund invests in companies which are attractively valued and demonstrate sustainable growth, along with a strong business model and sound balance sheet. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies. The Fund may use derivatives (complex instruments) to manage the Fund more efficiently, with the aim of reducing risk, reducing costs and/or generating additional capital or income. The Fund is actively managed and is not constrained by its benchmark, MSCI China A Onshore Health Care Index, which is used for comparison purposes. However, as the benchmark is a suitable proxy for the investment strategy, it is likely that some of the Fund"s holdings are also components of the benchmark. As an actively managed fund, this overlap will change and this statement may be updated from time to time.
 

Investment goal

The objective of the Fund is to achieve long term capital growth. The Fund invests in Chinese healthcare companies listed on the Shanghai or Shenzhen Stock Exchanges, traded via Stock Connect as well as those listed or traded elsewhere, included Qualified Foreign Investors (QFI). The Fund invests in companies which are attractively valued and demonstrate sustainable growth, along with a strong business model and sound balance sheet. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies.
 

Master data

Type of yield: reinvestment
Funds Category: Equity
Country: China
Branch: Sector Health / Pharma
Benchmark: MSCI China A Onshore Health Care Index
Business year start: 02-29
Last Distribution: -
Depository bank: -
Fund domicile: Luxembourg
Distribution permission: Austria, Germany, Switzerland, Luxembourg
Fund manager: Chris Liu, Kehong Jiang
Fund volume: 527.79 mill.  EUR
Launch date: 2020-12-15
Investment focus: -

Conditions

Issue surcharge: 5.00%
Max. Administration Fee: 1.00%
Minimum investment: 1,200,000.00 SGD
Deposit fees: 0.01%
Redemption charge: 0.00%
Key Investor Information: Download (Print version)
 

Investment company

Funds company: Invesco Management
Address: An der Welle 5, 60322, Frankfurt am Main
Country: Germany
Internet: www.de.invesco.com
 

Assets

Stocks
 
96.91%
Cash
 
3.09%

Countries

China
 
65.14%
Cash
 
3.09%
Cayman Islands
 
3.05%
Others
 
28.72%

Branches

Pharma/Biotechnology
 
50.29%
Healthcare appliances
 
14.53%
Healthcare services
 
3.36%
Cash
 
3.09%
Others
 
28.73%